4//SEC Filing
Spellacy Michael 4
Accession 0001104659-25-036892
CIK 0001868912other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:02 PM ET
Size
6.8 KB
Accession
0001104659-25-036892
Insider Transaction Report
Form 4
Enfusion, Inc.ENFN
Spellacy Michael
Director
Transactions
- Disposition to Issuer
Class A Common Stock
2025-04-21−56,810→ 0 total
Footnotes (4)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion.
- [F2]Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding was converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration").
- [F3]Represents shares of Common Stock and shares underlying restricted stock units of Enfusion, which were converted into the right to receive the merger consideration, at the election of the holder of such share of Common Stock.
- [F4]As a result of the consummation of the transactions contemplated Merger Agreement, the Reporting Person ceased to be the beneficial owner of any securities of Enfusion. This Form 4 constitutes an exit filing by the Reporting Person.
Documents
Issuer
Enfusion, Inc.
CIK 0001868912
Entity typeother
Related Parties
1- filerCIK 0001829665
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:02 PM ET
- Size
- 6.8 KB